Vol 10, No 3 (2021)
Other materials agreed with the Editors
Published online: 2021-02-18

open access

Page views 576
Article views/downloads 400
Get Citation

Connect on Social Media

Connect on Social Media

SARS-CoV uses ACE2 and CD209L receptors in infection

Fatima Rachidi1
Clin Diabetol 2021;10(3):243-244.

Abstract

Diabetes causes an increase in the expression of
Angiotensin-converting enzyme 2 (ACE 2). In fact, the
receptor ACE2 is a portal of entry of SARS-CoV. in this
discussion, we focus on another receiver, CD209L,
which also facilitates entry of SARS-CoV into the cell in
diabetic subjects.

Article available in PDF format

View PDF Download PDF file

References

  1. Berrou J, Fougeray S, Venot M, et al. Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes. PLoS One. 2013; 8(4): e62418.
  2. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009; 302(2): 193–202.
  3. Li J, Gao J, Xu YP, et al. Zhonghua Yi XueZaZhi. Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 and CD209L in different organ derived microvascular endothelial. 2007; 87(12): 833–837.
  4. Jeffers SA, Tusell SM, Gillim-Ross L, et al. CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A. 2004; 101(44): 15748–15753.
  5. Ilyas R, Wallis R, Soilleux EJ, et al. High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus. Immunobiology. 2011; 216(1-2): 126–131.